StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Zivo Bioscience's ebitda for the twelve months ending Jun 30, 2021 was -$8.95M. For fiscal 2021 it was -$8.65M. The highest annual figure on record is -$1.85M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2021Dec 31, 2021-$8.65M–
FY2020Dec 31, 2020-$8.56M–
FY2019Dec 31, 2019-$8.35M–
FY2018Dec 31, 2018-$6.13M–
FY2017Dec 31, 2017-$6.31M–
FY2016Dec 31, 2016-$3.47M–
FY2015Dec 31, 2015-$3.03M–
FY2014Dec 31, 2014-$5.13M–
FY2013Dec 31, 2013-$3.09M–
FY2012Dec 31, 2012-$2.01M–
FY2011Dec 31, 2011-$1.85M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2021Jun 30, 2021-$1.75M–
Q1 FY2021Mar 31, 2021-$2.08M–
Q4 FY2020Dec 31, 2020-$1.76M–
Q3 FY2020Sep 30, 2020-$3.36M–
Q2 FY2020Jun 30, 2020-$1.03M–
Q1 FY2020Mar 31, 2020-$2.41M–
Q4 FY2019Dec 31, 2019-$3.77M–
Q3 FY2019Sep 30, 2019-$1.57M–
Q2 FY2019Jun 30, 2019-$2.04M–
Q1 FY2019Mar 31, 2019-$967.85K–
Q4 FY2018Dec 31, 2018-$1.62M–
Q3 FY2018Sep 30, 2018-$1.49M–
Q2 FY2018Jun 30, 2018-$1.34M–
Q1 FY2018Mar 31, 2018-$1.68M–
Q4 FY2017Dec 31, 2017-$2.60M–
Q3 FY2017Sep 30, 2017-$2.05M–
Q2 FY2017Jun 30, 2017-$875.20K–
Q1 FY2017Mar 31, 2017-$785.02K–
Q4 FY2016Dec 31, 2016-$636.41K–
Q3 FY2016Sep 30, 2016-$670.87K–
Q2 FY2016Jun 30, 2016-$1.52M–
Q1 FY2016Mar 31, 2016-$634.31K–
Q4 FY2015Dec 31, 2015-$657.50K–

More Zivo Bioscience figures

See a number that looks wrong?